Comparative Pharmacology
Head-to-head clinical analysis: PEPCID PRESERVATIVE FREE versus RANICLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PEPCID PRESERVATIVE FREE versus RANICLOR.
PEPCID PRESERVATIVE FREE vs RANICLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive antagonist of histamine at H2 receptors on gastric parietal cells, inhibiting gastric acid secretion.
Ranitidine is a histamine H2-receptor antagonist that competitively inhibits the action of histamine on parietal cells, thereby reducing gastric acid secretion.
20 mg intravenously over at least 2 minutes or as an infusion over 15-30 minutes every 12 hours; alternatively, 20 mg orally once or twice daily.
12.5 mg orally twice daily, increased to 25 mg twice daily after 2 weeks if tolerated; maximum 50 mg twice daily.
None Documented
None Documented
2.5-3.5 hours (normal renal function); prolonged to 20-30 hours in severe renal impairment (CrCl <10 mL/min). Clinical context: dose adjustment required in renal insufficiency.
Terminal elimination half-life: 8-12 hours (mean 10 hours) in healthy adults; prolonged in renal impairment (up to 20 hours) and elderly.
Renal (65-70% unchanged by tubular secretion); minor biliary/fecal elimination (<30%). Clearance correlates with creatinine clearance.
Renal: 60-70% unchanged; biliary/fecal: 20-30% as metabolites; <10% in feces as unchanged drug.
Category C
Category C
H2 Receptor Antagonist
H2 Receptor Antagonist